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Until recently, training and education in resuscitation 
have received little attention in South Africa (SA). 
Despite the recognition of specialists in emergency 
medicine and the professionalisation of prehospital 
emergency care, international guidelines and 
consensus are often ignored and the lag between guideline publication 
and translation into clinical practice is protracted. South African 
literature should reflect the latest evidence to guide resuscitation and 
safe patient care. However, in the current South African Medicines 
Formulary (SAMF) (10th edition),[1] detail regarding these life-saving 
interventions is missing and erroneous, and incongruent with current 
international consensus. Most drugs that are commonly used during 
the management of cardiac arrest are reported incorrectly.
Adrenaline in cardiac arrest
The SAMF advocates ‘IV injection, 1 mg (10 ml 1:10  000) every 5 
cycles of CPR’ in an adult patient. This statement is incorrect. Five 
cycles of cardiopulmonary resuscitation (CPR) implies five cycles 
of 30 compressions followed by 2 ventilations. If performed at the 
required rate and efficiency, these 5 cycles would be complete in 
2 minutes. Giving adrenaline every 2 minutes is double the dose 
recommended by the international guidelines; the use of ‘mega-
dose’ adrenaline is potentially harmful and should not be used. 
The administration of 1  mg intravenous (IV)/intraosseous (IO) 
adrenaline is reasonable every 3 - 5 minutes during adult cardiac 
arrest.[2,3] 
For paediatric cardiac arrest, the SAMF correctly recommends 
adrenaline at 0.1  ml/kg/dose of a 1:10  000 solution; however, this 
should be given every 3 - 5 minutes rather than the 5 - 15 minutes 
cited.[1,4] Furthermore, the SAMF prescribes an IV infusion of 
0.1 - 1  mcg/kg/minute as an alternative in cardiac arrest. IV bolus 
administration is the preferred practice.[4] 
Adrenaline for asthma and anaphylaxis
According to the SAMF, adrenaline can be administered slowly via 
the IV route using 3 - 5 ml of a 1:10 000 solution (1 mg/10 ml) in 
asthma and acute anaphylaxis. This is extremely unsafe. For patients 
not in cardiac arrest, an IV adrenaline bolus dose of no more than 
0.05 -0.1  mg is recommended;[5] the SAMF suggests a much larger 
dosage which is not supported by any international guideline. 
Amiodarone in cardiac arrest
The SAMF states that ‘in acute resuscitation, slow IV boluses of 
150  mg may be given.’ This statement is not in accord with the 
International Liaison Committee on Resuscitation (ILCOR) and 
American Heart Association (AHA) treatment recommendations. 
If amiodarone is administered for refractory ventricular fibrillation 
or pulseless ventricular tachycardia, then a 300 mg bolus should be 
given 2 minutes after the first adrenaline dose. Should the patient 
remain in a shockable rhythm following a further 2 minutes of CPR, a 
defibrillation shock, another adrenaline dose, and another 2 minutes 
of CPR (5 cycles of 30:2), then a further 150 mg IV amiodarone may 
be administered. 
Atropine in asystole
The SAMF states that atropine may be administered to patients in 
asystole. This has not been part of the ILCOR recommendations 
since 2010. It should not be used.
Conclusion
The SAMF is a well-respected benchmark and vade mecum for the SA 
healthcare provider. It is vital that the text is correct, contemporary 
and follows international clinical guidelines to ensure consistent 
and safe patient care, particularly in the management of patients in 
extremis.
Response from the editors of the SAMF
Dawn Rossiter, Editor of the SAMF, and Marc Blockman, the 
Managing Editor, note the statement from the ARREST Special 
Interest Group of EMSSA.
Recommendations from the 2010 AHA guidelines for 
cardiopulmonary resuscitation and emergency cardiovascular care[2] 
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will be reflected in the next edition due for publication in January 
2014.
The aim of the SAMF is to promote safe and rational drug therapy, 
and we welcome all comments and constructive criticism.
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